归创通桥医疗科技股份有限公司
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability 2024-03-22 17:14
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions 2024-03-07 15:04
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE 2024-02-21 16:16
The 2023 Investor Open Day of Zylox-Tonbridge was successfully held 2023-12-05 22:22
Zylox-Tonbridge was Added to the FTSE Global Equity Index Series 2023-09-18 14:51
Zylox-Tonbridge's ZENFlow Tiger™ LD PTA Dilatation Catheter Receives ANVISA Marketing Approval 2023-08-31 11:31
Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan 2023-08-28 11:42
Zylox-Tonbridge to be Added to MSCI China All Shares Small Cap Index 2023-05-15 12:17
Zylox-Tonbridge enters into strategic cooperation with Hicicare for innovative Chinese vascular guidewires solutions 2023-04-24 10:36
Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million 2023-03-30 15:49
Zylox-Tonbridge Assisted Turkish Hospitals in Post-earthquake Recovery 2023-03-22 15:26
Zylox-Tonbridge maintains strong revenue and gross profit growth, including gross margin improvement driven by its platform-based strategy in 1H22 2022-08-18 14:57
1